Disordered Mineral Metabolism in Children with Chronic Kidney Disease: the Role of FGF-23

-
Investigator: Anthony A. Portale, MD
Sponsor: Abbott Laboratories

Location(s): United States

Description

Disturbances in mineral and bone metabolism in children with chronic kidney disease (CKD) lead to specific abnormalities of skeletal homeostasis called CKD-mineral and bone disorder (CKD-MBD).